AAP
YCBD icon

Arax Advisory Partners’s cbdMD YCBD Stock Holding History

Arax Advisory Partners’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Buy
+1
New +$1 ﹤0.01% 5203

Other funds holding YCBD

WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $4.36B AUM 19.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Arax Advisory Partners's YCBD Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in cbdMD (YCBD) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #5203 among its holdings.

27 funds tracked by Wall St. Rank hold YCBD as of Q2 2026.

  • Arax Advisory Partners held 1 share of cbdMD worth $1 as of Q2 2026.
  • cbdMD was a new Arax Advisory Partners position in Q2 2026.
  • cbdMD made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5203 holding.
  • 27 funds tracked by Wall St. Rank held cbdMD as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.